How confident can we be in the current guidelines for exiting cervical screening?

Area of Science:

• Gynecology
• Public Health
• Epidemiology

Background:

• Current US guidelines advise against cervical cancer screening for women over 65 with adequate negative screening history.
• These recommendations were based on cytology alone and may not apply to newer screening strategies like HPV testing.
• Newer insights into HPV natural history and changing sexual behaviors impact risk assessment in older populations.

Purpose of the Study:

• Critically review evidence supporting current US cervical screening cessation guidelines for women over 65.
• Highlight practice changes and new epidemiological data on HPV and cervical cancer.
• Identify research priorities for evidence-based updates to screening guidelines.

Main Methods:

• Literature review and critical analysis of existing evidence.
• Examination of HPV epidemiology and cervical cancer natural history.
• Discussion of limitations in current screening definitions and risk prediction models.

Main Results:

• Existing guidelines may lack generalizability to modern screening methods (co-testing, primary HPV testing).
• Defining 'adequate negative screening' is challenging due to lack of empirical data and evolving risk factors.
• Extrapolating past risk data to current post-menopausal populations may be unreliable.

Conclusions:

• Caution is urged when applying past risk data to current older populations.
• Further research is needed to strengthen the evidence base for screening well-screened older women.
• Balancing screening benefits (cancer reduction) against harms (overscreening) requires updated metrics beyond colposcopy rates.